Addressing the ethical issues raised by synthetic human entities with embryo-like features
- PMID: 28494856
- PMCID: PMC5360441
- DOI: 10.7554/eLife.20674
Addressing the ethical issues raised by synthetic human entities with embryo-like features
Erratum in
-
Correction: Addressing the ethical issues raised by synthetic human entities with embryo-like features.Elife. 2017 Apr 13;6:e27642. doi: 10.7554/eLife.27642. Elife. 2017. PMID: 28494857 Free PMC article. No abstract available.
Abstract
The "14-day rule" for embryo research stipulates that experiments with intact human embryos must not allow them to develop beyond 14 days or the appearance of the primitive streak. However, recent experiments showing that suitably cultured human pluripotent stem cells can self-organize and recapitulate embryonic features have highlighted difficulties with the 14-day rule and led to calls for its reassessment. Here we argue that these and related experiments raise more foundational issues that cannot be fixed by adjusting the 14-day rule, because the framework underlying the rule cannot adequately describe the ways by which synthetic human entities with embryo-like features (SHEEFs) might develop morally concerning features through altered forms of development. We propose that limits on research with SHEEFs be based as directly as possible on the generation of such features, and recommend that the research and bioethics communities lead a wide-ranging inquiry aimed at mapping out solutions to the ethical problems raised by them.
Keywords: 14 day rule; Embryo and stem cell ethics; developmental biology; stem cells; tissue engineering.
Conflict of interest statement
GMC: George Church is actively involved with companies commercializing synthetic biology. His financial interests are specified on his website: http://arep.med.harvard.edu/gmc/tech.html. Additionally, this article was supported by two grants from the NIH (Grants RM1HG008525 and P50HG005550). George Church is a founder and has a financial interest in two companies, Editas and ReadCoor, that are related to those grants. Additionally, potentially relevant patents to this article have been submitted. The companies have not had a role in the study design, data collection and analysis, decision to publish or preparation of the present manuscript.
The other authors declare that no competing interests exist.
Figures
References
-
- Al-Chaer ED. Neuroanatomy of Pain and Pain Pathways. In: Moore R. J, editor. Handbook of Pain and Palliative Care. New York: Springer-Verlag; 2012. pp. 273–294.
-
- Baltimore D, Berg P, Botchan M, Carroll D, Charo RA, Church G, Corn JE, Daley GQ, Doudna JA, Fenner M, Greely HT, Jinek M, Martin GS, Penhoet E, Puck J, Sternberg SH, Weissman JS, Yamamoto KR. Biotechnology. A prudent path forward for genomic engineering and germline gene modification. Science. 2015;348:36–38. doi: 10.1126/science.aab1028. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
